Ubs Asset Management Americas Inc Revolution Medicines, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $379 Billion
  • Q1 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 300,196 shares of RVMD stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300,196
Previous 262,851 14.21%
Holding current value
$11.1 Million
Previous $11.5 Million 7.68%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 19, 2025
BUY
$35.36 - $44.42 $1.32 Million - $1.66 Million
37,345 Added 14.21%
300,196 $10.6 Million
Q4 2024

Feb 14, 2025
BUY
$42.97 - $60.6 $2.01 Million - $2.84 Million
46,825 Added 21.68%
262,851 $11.5 Million
Q3 2024

Nov 14, 2024
SELL
$36.92 - $47.94 $938,543 - $1.22 Million
-25,421 Reduced 10.53%
216,026 $9.79 Million
Q2 2024

Aug 13, 2024
BUY
$30.14 - $40.68 $3.26 Million - $4.4 Million
108,273 Added 81.3%
241,447 $9.37 Million
Q4 2023

Feb 14, 2024
BUY
$18.35 - $34.12 $530,975 - $987,296
28,936 Added 27.76%
133,174 $3.82 Million
Q3 2023

Nov 13, 2023
BUY
$25.17 - $35.05 $350,190 - $487,650
13,913 Added 15.4%
104,238 $2.89 Million
Q1 2023

May 15, 2023
BUY
$20.76 - $30.09 $569,322 - $825,188
27,424 Added 43.6%
90,325 $1.96 Million
Q4 2022

Feb 14, 2023
BUY
$17.68 - $25.53 $334,328 - $482,772
18,910 Added 42.99%
62,901 $1.5 Million
Q3 2022

Nov 14, 2022
BUY
$17.46 - $26.0 $8,049 - $11,986
461 Added 1.06%
43,991 $867,000
Q2 2022

Aug 12, 2022
SELL
$14.54 - $27.17 $203,676 - $380,597
-14,008 Reduced 24.35%
43,530 $848,000
Q1 2022

May 16, 2022
BUY
$17.31 - $26.4 $289,492 - $441,513
16,724 Added 40.98%
57,538 $1.47 Million
Q4 2021

Feb 14, 2022
BUY
$24.35 - $33.7 $48,261 - $66,793
1,982 Added 5.1%
40,814 $1.03 Million
Q3 2021

Nov 15, 2021
BUY
$23.95 - $33.41 $8,909 - $12,428
372 Added 0.97%
38,832 $1.07 Million
Q2 2021

Aug 16, 2021
BUY
$29.0 - $47.44 $468,640 - $766,630
16,160 Added 72.47%
38,460 $1.22 Million
Q1 2021

May 14, 2021
SELL
$37.21 - $54.43 $94,104 - $137,653
-2,529 Reduced 10.19%
22,300 $1.02 Million
Q4 2020

Mar 01, 2021
BUY
$30.19 - $45.49 $535,238 - $806,492
17,729 Added 249.7%
24,829 $982,000
Q3 2020

Nov 13, 2020
BUY
$22.61 - $34.8 $160,531 - $247,079
7,100 New
7,100 $247,000

Others Institutions Holding RVMD

# of Institutions
306
Shares Held
189M
Call Options Held
186K
Put Options Held
672K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.25B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email